Literature DB >> 16337789

Biological evaluation of isothiazoloquinolones containing aromatic heterocycles at the 7-position: In vitro activity of a series of potent antibacterial agents that are effective against methicillin-resistant Staphylococcus aureus.

Jason A Wiles1, Yongsheng Song, Qiuping Wang, Edlaine Lucien, Akihiro Hashimoto, Jijun Cheng, Christopher W Marlor, Yangsi Ou, Steven D Podos, Jane A Thanassi, Christy L Thoma, Milind Deshpande, Michael J Pucci, Barton J Bradbury.   

Abstract

We synthesized a diverse series of 9H-isothiazolo[5,4-b]quinoline-3,4-diones containing heteroaromatic groups at the 7-position via palladium-catalyzed cross-coupling. Many of these compounds demonstrated potent antistaphylococcal activity (MICs 2 microg/mL) against a multi-drug-resistant strain (ATCC 700699) and low cytotoxic activity (CC(50)>100 microM) against the human cell line Hep2 (laryngeal carcinoma).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16337789     DOI: 10.1016/j.bmcl.2005.11.064

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.

Authors:  Michael J Pucci; Jijun Cheng; Steven D Podos; Christy L Thoma; Jane A Thanassi; Douglas D Buechter; Gohar Mushtaq; Gerald A Vigliotti; Barton J Bradbury; Milind Deshpande
Journal:  Antimicrob Agents Chemother       Date:  2007-01-22       Impact factor: 5.191

Review 2.  A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.

Authors:  Gregory S Bisacchi; Michael R Hale
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

3.  In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.

Authors:  Carmen A Molina-Torres; Jorge Ocampo-Candiani; Adrian Rendón; Michael J Pucci; Lucio Vera-Cabrera
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

4.  In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens.

Authors:  Michael J Pucci; Steven D Podos; Jane A Thanassi; Melissa J Leggio; Barton J Bradbury; Milind Deshpande
Journal:  Antimicrob Agents Chemother       Date:  2011-04-04       Impact factor: 5.191

5.  Drug-resistant tuberculosis: emerging treatment options.

Authors:  Meghna Adhvaryu; Bhasker Vakharia
Journal:  Clin Pharmacol       Date:  2011-12-14

6.  Intracellular activity of tedizolid phosphate and ACH-702 versus Mycobacterium tuberculosis infected macrophages.

Authors:  Carmen A Molina-Torres; Alejandra Barba-Marines; Orestes Valles-Guerra; Jorge Ocampo-Candiani; Norma Cavazos-Rocha; Michael J Pucci; Jorge Castro-Garza; Lucio Vera-Cabrera
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-04-04       Impact factor: 3.944

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.